Prelude Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $780K | Sell |
|
|||||
|
2024
Q4 | $1.14M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $336K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $966K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.5M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $891K | Buy |
|
|||||
|
2020
Q3 | $661K | Sell |
|
|||||
|
2020
Q2 | $2.08M | Buy |
|
|||||
|
2020
Q1 | $2K | Sell |
|
|||||
|
2019
Q4 | $1.78M | Sell |
|
|||||
|
2019
Q3 | $1.67M | Buy |
|
|||||
|
2019
Q2 | $932K | Buy |
|
|||||
|
2019
Q1 | $754K | Sell |
|
|||||
|
2018
Q4 | $1.87M | Buy |
|
|||||
|
2018
Q3 | $945K | Sell |
|
|||||
|
2018
Q2 | $1.1M | Sell |
|
|||||
|
2018
Q1 | $2.35M | Buy |
|
|||||
|
2017
Q4 | $858K | Sell |
|
|||||
|
2017
Q3 | $1.36M | Buy |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1.08M | Buy |
|
|||||
|
2016
Q2 | $739K | Sell |
|
|||||
|
2016
Q1 | $715K | Buy |
|
|||||
|
2015
Q4 | $397K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $493K | Buy |
|
|||||
|
2014
Q4 | $334K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $87K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $92K | Buy |
|